-- SpePharm Savene
Extravasation
The Product
Mechanism of Action
Efficacy
Tolerability
Administration
SmPC
Presentations
Publications
Summary
References


Savene® - an innovative answer to an old problem


Savene® is an innovative systemic antidote that protects against tissue damage due to anthracycline extravasation. It is: 
   

Proven for anthracycline extravasation
   

Highly effective in avoiding tissue damage after extravasation

   

Supported by both preclinical and clinical studies

Savene® is the only drug approved in the EU for the treatment of extravasations caused by anthracyclines such as:

    - Doxorubicin

    - Epirubicin

    - Daunorubicin

    - Idarubicin


 
Savene® should be available during every anthracycline chemotherapy session